Jiangxi Rimag Group Co., Ltd, a leading medical imaging services provider based in China, has set the pricing range for its initial public offering (IPO) on the Hong Kong Stock Exchange. The price band is set between HKD 14.6 and 16.8 per share, which equates to approximately USD 1.87 to 2.15. Established in 2014, Rimag specializes in establishing and operating medical imaging center networks and is at the forefront of exploring innovative service models under China’s tiered diagnosis and treatment system. The company is recognized as the premier player in third-party medical imaging operations across various metrics, including the number of branches, equipment range, registered licensed imaging doctors, daily examination volumes, and patient fees.
In 2022, Rimag achieved revenues of RMB 929 million and recorded adjusted net profits of RMB 59.996 million.
Additionally, New Ray Medicine International Holding Ltd (HKG: 6108) has committed to becoming Rimag’s cornerstone investor, with a subscription to purchase shares worth HKD 12 million.- Flcube.com
